Li, Qiao
Cheng, Ying http://orcid.org/0000-0001-9908-597X
Tong, Zhongsheng
Liu, Yunjiang
Wang, Xian
Yan, Min http://orcid.org/0000-0002-3911-748X
Chang, Jianhua
Wang, Shusen http://orcid.org/0000-0003-0139-5780
Du, Caiwen
Li, Liang
Wu, Chunjiao
Wang, Mingxia
Wang, Zhuo
Wu, Zhuli
Wang, Xingli
Jin, Yongli
Diao, Lei
Sun, Yi
Zhang, Yongjiao
Hui, Ai-Min
Xu, Binghe http://orcid.org/0000-0003-4195-337X
Article History
Received: 25 September 2023
Accepted: 14 May 2024
First Online: 17 June 2024
Competing interests
: Zhuli W., Xingli W., Y.J., L.D., Y.S. and Y.Z. are employees of Fosun Pharmaceutical Development Co., Ltd.. B.X. reports receiving advisory fees from Novartis and AstraZeneca and fees for serving on a speakers’ bureau from Pfizer and Roche. Other authors have no competing interests.